Our findings provide the first evidence of a critical role of serglycin in regulating the cargo and functions of tumor-derived exosomes and have a broad significance since a role for serglycin in different cancer progression (such as breast, lung, nasopharyngeal) is recently becoming apparent. The gene discussed is SRGN; the disease is neoplasm.